Literature DB >> 20238197

Bupropion induced serotonin syndrome: a case report.

Elizabeth L Thorpe1, Anthony F Pizon, Michael J Lynch, Jessica Boyer.   

Abstract

Although there are no documented cases of serotonin syndrome (SS) following bupropion ingestion alone in the literature, the ability of bupropion to potentiate serotonin levels and lead to SS is known. A 15-year-old boy was found at home hallucinating. He then developed tonic-clonic activity. Upon arrival in the emergency department, he was confused and restless. On exam, he had tachycardia, hypertension, dilated pupils and dry oral mucosa, normal tone and reflexes in his arms, but rigidity and +4 reflexes in his legs with sustained clonus at his ankles. He was admitted and treated with intravenous fluids and lorazepam for his agitation. A urine drug screen (via gas chromatography/mass spectrometry) was positive only for naproxen and bupropion. Serum bupropion and hydroxybupropion levels drawn 17 h after his reported ingestion were 280 (therapeutic range 50-100) and 3,100 ng/mL (therapeutic range <485), respectively. Within 24 h of his admission, the patient was awake with normal vital signs and neurologic exam. To our knowledge, there are only three reported cases demonstrating SS in conjunction with bupropion toxicity; however, none of these were secondary to bupropion alone.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20238197      PMCID: PMC3550303          DOI: 10.1007/s13181-010-0021-x

Source DB:  PubMed          Journal:  J Med Toxicol        ISSN: 1556-9039


  5 in total

1.  Serotonin Syndrome With Fluoxetine: Two Case Reports.

Authors:  Dipen Dineshkumar Patel; David Galarneau
Journal:  Ochsner J       Date:  2016

2.  Challenges in a large mixed drug overdose patient.

Authors:  Paige Zhang; Emily Austin; Margaret Thompson; Steve Lin
Journal:  BMJ Case Rep       Date:  2016-06-22

3.  Pediatric Bupropion Ingestions in Adolescents vs. Younger Children-a Tale of Two Populations.

Authors:  Steve Offerman; Michael Levine; Jasmin Gosen; Stephen H Thomas
Journal:  J Med Toxicol       Date:  2019-11-11

4.  Single-Agent Bupropion Exposures: Clinical Characteristics and an Atypical Cause of Serotonin Toxicity.

Authors:  Brian Murray; Joseph Carpenter; Camille Dunkley; Tim P Moran; Emily A Kiernan; Tony Rianprakaisang; Waleed S Alsukaiti; Diane P Calello; Ziad Kazzi
Journal:  J Med Toxicol       Date:  2019-12-10

5.  Urinary Incontinence during Sleep Associated with Extended Release Form of Bupropion HCI.

Authors:  Filiz Izci; Merve Iris Koc; Rabia Bilici; Murat Yalcin; Engin Emrem Bestepe
Journal:  Case Rep Psychiatry       Date:  2015-11-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.